Learn how industry partners evaluate research collaborations and technology licensing opportunities: type of data they look for, how to speak their language and what questions to expect.
Keynote Speaker: FRANK TAFFY, JD Senior Vice President and Head of Business Development, Schrödinger, Inc
Frank has over 20 years of experience in life sciences corporate development and business operations. He received his bachelor’s degree in biochemistry from the University of North Texas and his law degree from Syracuse University. He began his career as an intellectual property transactional attorney at Procter and Gamble. He cofounded Helocyte and Cellvation, both clinical-stage biopharmaceutical companies with which he remains a Board member, and worked at Forest Laboratories, Inc. (now AbbVie, Inc.) where he led the optimization and expansion of the company’s portfolio of marketed pharmaceutical products. Prior to joining Forest, Frank served as Director of Corporate Development at Life Technologies, Inc. where he led partnering and investment activities.
Following Frank’s keynote address, there will be lightning talks focusing on Innovation Ventures, including New Ventures, Commercialization Funding and I-Corps. The webinar will conclude with a panel discussion on effective partnerships with industry, where each panelist will share their journey, offer advice, and discuss the success of the Rutgers-Horizon Discovery partnership.
To register and for more information, click here: Innovation Ventures Road to Commercialization Symposium Series (Summer 2022)
Date & Time
August 4, 2022
9:30 am-12:30 pm